Open Access. Powered by Scholars. Published by Universities.®

Pharmacy and Pharmaceutical Sciences Commons™

Open Access. Powered by Scholars. Published by Universities.®

Discipline
Institution
Keyword
Publication Year
Publication
Publication Type
File Type

Articles 1591 - 1620 of 9516

Full-Text Articles in Pharmacy and Pharmaceutical Sciences

Research News, Publications, 2024, Volume 3, Soumyajit Majumdar Jan 2024

Research News, Publications, 2024, Volume 3, Soumyajit Majumdar

Publications (2015-)

Publications that appeared during the period of July 1 through September 30, 2024.


Research News, Publications, 2024, Volume 4, Joshua Sharp Jan 2024

Research News, Publications, 2024, Volume 4, Joshua Sharp

Publications (2015-)

Publications that appeared during the period of October 1 - December 31, 2024.


Research News, Grants, 2024, Volume 3, Soumyajit Majumdar Jan 2024

Research News, Grants, 2024, Volume 3, Soumyajit Majumdar

Grants (2015-)

Grants and contracts awarded during July - September 2024 - Revised 10/22/24


Research News, Grants, 2024, Volume 4, Joshua Sharp Jan 2024

Research News, Grants, 2024, Volume 4, Joshua Sharp

Grants (2015-)

Grants and contracts awarded during October - December 2024


A Real-World Disproportionality Analysis Of Everolimus: Data Mining Of The Public Version Of Fda Adverse Event Reporting System, Bin Zhao, Yumei Fu, Shichao Cui, Xiangning Chen, Shu Liu, Lan Luo Jan 2024

A Real-World Disproportionality Analysis Of Everolimus: Data Mining Of The Public Version Of Fda Adverse Event Reporting System, Bin Zhao, Yumei Fu, Shichao Cui, Xiangning Chen, Shu Liu, Lan Luo

Faculty, Staff and Student Publications

Background: Everolimus is an inhibitor of the mammalian target of rapamycin and is used to treat various tumors. The presented study aimed to evaluate the Everolimus-associated adverse events (AEs) through data mining of the US Food and Drug Administration Adverse Event Reporting System (FAERS).

Methods: The AE records were selected by searching the FDA Adverse Event Reporting System database from the first quarter of 2009 to the first quarter of 2022. Potential adverse event signals were mined using the disproportionality analysis, including reporting odds ratio the proportional reporting ratio the Bayesian confidence propagation neural network and the empirical Bayes geometric …


Targeting The Renin-Angiotensin System (Ras) For Neuropsychiatric Disorders, Aline Silva De Miranda, Danielle S Macedo, Natalia P Rocha, Antonio L Teixeira Jan 2024

Targeting The Renin-Angiotensin System (Ras) For Neuropsychiatric Disorders, Aline Silva De Miranda, Danielle S Macedo, Natalia P Rocha, Antonio L Teixeira

Faculty, Staff and Student Publications

BACKGROUND: Neuropsychiatric disorders, such as mood disorders, schizophrenia, and Alzheimer's disease (AD) and related dementias, are associated to significant morbidity and mortality worldwide. The pathophysiological mechanisms of neuropsychiatric disorders remain to be fully elucidated, which has hampered the development of effective therapies. The Renin Angiotensin System (RAS) is classically viewed as a key regulator of cardiovascular and renal homeostasis. The discovery that RAS components are expressed in the brain pointed out a potential role for this system in central nervous system (CNS) pathologies. The understanding of RAS involvement in the pathogenesis of neuropsychiatric disorders may contribute to identifying novel therapeutic …


Treatment Patterns And Clinical And Economic Burden In Patients With Merkel Cell Carcinoma: Statistical And Machine Learning Approaches, Yves Mbous Jan 2024

Treatment Patterns And Clinical And Economic Burden In Patients With Merkel Cell Carcinoma: Statistical And Machine Learning Approaches, Yves Mbous

Graduate Theses, Dissertations, and Problem Reports (ETD)

Although considered a rare form of nonmelanoma skin cancer, Merkel Cell Carcinoma incidence rate has increased to 0.74 per 100,000 and projections expect this number to steadily rise over the next decades and to reach an average of 3,285 cases per year in 2025. MCC incidence increases significantly with age. Among those aged 40-44, it is 0.44, it rises to 1.0/100,000 in the 60-64 age group and soars to 9.8/100,000 among those ≥85 years and above. Due to the small number of cases, MCC is often managed using institutional practices or provider preferences. Formal clinical trials that enroll early stage …


Management Of Factor Xa Inhibitor-Related Traumatic Non-Intracranial Bleeding Events With Andexanet Alfa Or Four-Factor Prothrombin Complex Concentrate In A Us Multicenter Observational Study, Paul P. Dobesh, Craig I. Coleman, Mark Danese, Eva Lesén, Raymond C. Chang, Onivefu Odelade, Gregory J. Fermann Jan 2024

Management Of Factor Xa Inhibitor-Related Traumatic Non-Intracranial Bleeding Events With Andexanet Alfa Or Four-Factor Prothrombin Complex Concentrate In A Us Multicenter Observational Study, Paul P. Dobesh, Craig I. Coleman, Mark Danese, Eva Lesén, Raymond C. Chang, Onivefu Odelade, Gregory J. Fermann

Journal Articles: Pharmacy Practice

OBJECTIVES: This study describes clinical characteristics and management strategies for patients with factor Xa (FXa) inhibitor-related traumatic non-intracranial bleeds who were treated with andexanet alfa or four-factor prothrombin complex concentrate (4F-PCC).

METHODS: An observational cohort study (ClinicalTrials.gov Identifier: NCT05548777) was conducted using electronic health records from 354 US hospitals. Included patients were hospitalized with rivaroxaban- or apixaban-related bleeding, had received andexanet alfa or 4F-PCC treatment during their hospitalization, and were discharged between May 2018 and September 2022. This analysis was performed in the subgroup of patients with traumatic non-intracranial critical compartment/non-compressible bleeds or other traumatic bleeds.

RESULTS: The study population …


Andexanet Alfa Versus Pcc Products For Factor Xa Inhibitor Bleeding: A Systematic Review With Meta-Analysis, C. Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V. Hernandez, William L. Baker, Paul P. Dobesh, Heleen Van Haalen, Kirsty Rhodes, Craig I. Coleman Jan 2024

Andexanet Alfa Versus Pcc Products For Factor Xa Inhibitor Bleeding: A Systematic Review With Meta-Analysis, C. Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V. Hernandez, William L. Baker, Paul P. Dobesh, Heleen Van Haalen, Kirsty Rhodes, Craig I. Coleman

Journal Articles: Pharmacy Practice

Previous meta-analyses assessed andexanet alfa (AA) or prothrombin complex concentrate (PCC) products for the treatment of Factor Xa inhibitor (FXaI)-associated major bleeding. However, they did not include recent studies or assess the impact of the risk of bias. We conducted a systematic review with meta-analysis on the effectiveness of AA versus PCC products for FXaI-associated major bleeding, inclusive of the studies' risk of bias. PubMed and Embase were searched for comparative studies assessing major bleeding in patients using FXaI who received AA or PCC. We used the Methodological Index for NOn-Randomized Studies (MINORS) checklist and one question from the Joanna …


The Impact Of Candida Albicans Glycogen On Fitness, Virulence And Host Response, Jian Miao Jan 2024

The Impact Of Candida Albicans Glycogen On Fitness, Virulence And Host Response, Jian Miao

Theses and Dissertations (ETD)

Candida albicans is an opportunistic human fungal pathogen that presents in healthy persons colonizing the oropharyngeal, esophageal, and gastrointestinal mucosa. This polymorphic fungal pathogen remains a leading cause of both invasive and superficial mycoses. C. albicans can cause oropharyngeal candidiasis (OPC) and disseminated candidiasis when normal host immunity is disturbed, while also causing vulvovaginal candidiasis (VVC) in healthy women. Adaptation to different host niches requires rapid and coordinated changes in Candida metabolism and physiology to cope with host immune surveillance and to counteract host-imposed constraints such as glucose limitation. Although largely unexplored in C. albicans, the glycogen metabolism pathway is …


Relationship Of Serum Copeptin Level With Traditional Risk Factors For Acute Coronary Syndrome In Early Diagnosis Of This Syndrome In Iraqi Patients, Ali Abdul Rasool Hussein, Abdulkareem H. Issa, Abbas Naji Muslem Al Shareeifi Jan 2024

Relationship Of Serum Copeptin Level With Traditional Risk Factors For Acute Coronary Syndrome In Early Diagnosis Of This Syndrome In Iraqi Patients, Ali Abdul Rasool Hussein, Abdulkareem H. Issa, Abbas Naji Muslem Al Shareeifi

Al-Esraa University College Journal for Medical Sciences

Background: Acute coronary syndrome (ACS) is still one of the main causes of morbidity and mortality worldwide and an early diagnosis of myocardial infarction (MI) aims to decrease mortality in MI patients. The ACS is manifested as one of three subtypes. These subtypes include MI with the electrocardiogram (ECG) is showing ST-segment elevation (STEMI), the other is MI with the ECG is showing no ST-segment elevation (NSTEMI) and the third type is unstable angina (UA). Objectives: To explore the Relationship of serum copeptin level with traditional risk factors for acute coronary syndrome in early diagnosis of this syndrome in Iraqi …


Immunological And Molecular Investigation Of Non-Helicobacter Pylori Gastritis Within Type 2 Diabetes Mellitus, Zahraa Maad Abdul-Sahib, Najah Ali Mohammad, Abdul Razzaq Nema Jan 2024

Immunological And Molecular Investigation Of Non-Helicobacter Pylori Gastritis Within Type 2 Diabetes Mellitus, Zahraa Maad Abdul-Sahib, Najah Ali Mohammad, Abdul Razzaq Nema

Al-Esraa University College Journal for Medical Sciences

Gastritis is one of the most common diseases in the digestive system, especially in patients with low immunity, including diabetic mellitus. Diabetic Mellitus considered one of an endocrine gland disease characterized by elevated blood sugar because of a defect in the regulation of sugar in the body. The purpose of this study was to assess the association between Non-Helicobacter pylori gastritis with type 2 diabetic mellitus (N-Hp G.T2DM), by interleukin IL-10 and IL-18. This study included 37(41.1%) N-Hp G.T2DM, 23 (25.6%) gastritis (G) only and 30 (33.3%) healthy participants. Biomarkers for T2DM and G (FBS, …


Investigating The Association Of Demographic Factors On Methotrexate Delay-Clearance And Toxicity In Pediatric Oncology Patients: A Retrospective Chart Review, Belal Alabdul Razzak Jan 2024

Investigating The Association Of Demographic Factors On Methotrexate Delay-Clearance And Toxicity In Pediatric Oncology Patients: A Retrospective Chart Review, Belal Alabdul Razzak

Honors Undergraduate Theses

High-dose methotrexate (HD MTX) is critical for treating pediatric malignancies such as acute lymphoblastic leukemia and neuro-carcinoma. However, its significant toxicity due to drug accumulation poses substantial risks. This retrospective study assesses the impact of demographic factors on MTX toxicity and clearance in pediatric oncology patients. Patient records from Saint Mary Hospital were analyzed, focusing on two MTX administration protocols: a 24-hour infusion followed by alkaline hydration and a 4-hour infusion followed by alkaline hydration. We hypothesize that factors such as age, body surface area (BSA), and body mass index (BMI) are associated with MTX clearance and toxicity. The study …


Strategies And Emerging Mechanisms In Managing Pseudomonas Aeruginosa Biofilm-Associated Antibiotic Resistance In Renal Catheters, Ahmed Fadhil Kadhim Jan 2024

Strategies And Emerging Mechanisms In Managing Pseudomonas Aeruginosa Biofilm-Associated Antibiotic Resistance In Renal Catheters, Ahmed Fadhil Kadhim

Al-Esraa University College Journal for Medical Sciences

Strategies and mechanisms in controlling Pseudomonas aeruginosa resistance to biofilm-associated with renal catheters are a serious concern. Renal catheters are widely used in hospitals for numerous urological disorders. However, they are the main cause of bacterial infections, especially P. aeruginosa, when used for a long time. The mechanism of biofilm-associated antibiotic resistance of P. aeruginosa in renal catheters is complex and has not been efficiently managed. This review debates certain strategies and mechanisms associated with P. aeruginosa biofilm antibiotic resistance in cases with renal catheters, including the prevention of biofilm formation, eradication of biofilm, and reducing biofilm-associated antibiotic resistance and …


Distribution Of Epidemiological Characteristics Among Drug Addiction Patients Admitted To Alqana Center For Social Rehabilitation, Ali Abdul Alkhudhur Murad, Atta Ah. Mousa Al-Sarray, Zeena Jamal Alkhazraji Jan 2024

Distribution Of Epidemiological Characteristics Among Drug Addiction Patients Admitted To Alqana Center For Social Rehabilitation, Ali Abdul Alkhudhur Murad, Atta Ah. Mousa Al-Sarray, Zeena Jamal Alkhazraji

Al-Esraa University College Journal for Medical Sciences

Background: Drug addiction is a worldwide issue; 5.6% of the world's population aged 15 to 64 took drugs at least once in 2016. For the majority of medicines, younger individuals use them more than older people do. Drug abuse seems to be on the increase in several ASEAN (Association of Southeast Asian Nations) countries, particularly among young men aged 15 to 30. Illicit drug abuse account for around 14% of the overall health burden among young males. Younger individuals are also more prone to die from drug abuse issues. Aim: To assess the severity of problems related to drug …


Immunological Markers And Clinical Features With Systemic Lupus Erythematosus In Iraqi Women Patients, Ali Yahya. Zeki, Ali Hussein. Al-Hafid, Haider Hafudh Humaish Jan 2024

Immunological Markers And Clinical Features With Systemic Lupus Erythematosus In Iraqi Women Patients, Ali Yahya. Zeki, Ali Hussein. Al-Hafid, Haider Hafudh Humaish

Al-Esraa University College Journal for Medical Sciences

Background: Systemic Lupus Erythematosus is a complicated condition caused by the immune system attacking disease with unclear causes, affecting mainly women. It manifests with various symptoms and is diagnosed based on clinical and serological signs. Aims: To investigate the prevalence and the type of immunological and hematologic manifestations in SLE from pathologist's perspective. Methods: The study was done on 60 SLE patients and 60 controls from the Consulting Rheumatology Clinic in Baghdad Teaching Hospital in Baghdad City during the first half of the year 2024, from 25th January 2024 until 25th April 2024. Results: Marital state …


Cathepsin D And Its Relation With Lipid Profile In Coronary Atherosclerosis Patients, Israa Saad Salim, Walaa Ismael Jassim, Ahmed Saadi Hassan Jan 2024

Cathepsin D And Its Relation With Lipid Profile In Coronary Atherosclerosis Patients, Israa Saad Salim, Walaa Ismael Jassim, Ahmed Saadi Hassan

Al-Esraa University College Journal for Medical Sciences

Background: Coronary atherosclerosis is a long lasting and continuously evolving disease with multiple clinical manifestations ranging from asymptomatic to stable angina, acute coronary syndrome (ACS), heart failure (HF) and sudden cardiac death (SCD). The onset and advancement of coronary atherosclerosis are influenced by both genetic and environmental factors. Objectives: The study aimed to find out if cathepsin D a good indicator to diagnose atherosclerosis and cardiovascular diseases and its relation with lipid profile. Materials and Methods: The study conducted with the participation of 150 subjects (100 patients with coronary atherosclerosis and 50 healthy control). Age for all subject was in …


Secretor Status And Anxiety Are Risk Factors For Getting Irritable Bowel Syndrome, Ola Amer Jasim, Khalid Mahdi Salih Jan 2024

Secretor Status And Anxiety Are Risk Factors For Getting Irritable Bowel Syndrome, Ola Amer Jasim, Khalid Mahdi Salih

Al-Esraa University College Journal for Medical Sciences

Irritable Bowel Syndrome (IBS) is a functional disease of gastrointestinal tract (GIT) that affects 10-20% of the population worldwide and is distinguished by abdominal pain/discomfort and changes in bowel habits that is accompanied by diarrhea, constipation, or both. Control-based study was conducted on 50 Iraqi patients with IBS who were presented at private clinics for gastrointestinal diseases (GIDs), along with 20 healthy individuals matched in their age and gender to act as control group. The study lasted from November 2021 to May 2022 and aimed to determine the frequency of IBS subtypes among Iraqi patients, as well as the influence …


Complement Component C3 And C4 Levels In Juvenile And Adult Sle Iraqi Patients, Sahar S. Aldhahir, Izzat A. M. Al-Rayahi, Salwa S. Muhsin Jan 2024

Complement Component C3 And C4 Levels In Juvenile And Adult Sle Iraqi Patients, Sahar S. Aldhahir, Izzat A. M. Al-Rayahi, Salwa S. Muhsin

Al-Esraa University College Journal for Medical Sciences

Background: Systemic lupus erythematosus (SLE) is an autoimmune disease, with about 15-20% of patients being children. The causes of the disease are a mix of genetic and environmental factors. Complement C3 and C4 play a significant role in the diagnosis and monitoring of disease severity. Additionally, renal function tests are important for monitoring the disease, as the disease affects the kidneys in a large percentage of patients. Aim: The study was primarily conducted to compare complement C3 and C4 levels in Iraqi adult and juvenile patients with systemic lupus erythematosus. Patient and methods: The study consisted of 70 patients, …


Carfilzomib-Loaded Ternary Polypeptide Nanoparticles Stabilized By Polycationic Complexation, Preye Mike Agbana, Ji Eun Park, Piotr G. Rychahou, Kyung-Bo Kim, Younsoo Bae Jan 2024

Carfilzomib-Loaded Ternary Polypeptide Nanoparticles Stabilized By Polycationic Complexation, Preye Mike Agbana, Ji Eun Park, Piotr G. Rychahou, Kyung-Bo Kim, Younsoo Bae

Markey Cancer Center Faculty Publications

Carfilzomib (CFZ) is a second-generation proteasome inhibitor showing great efficacy in multiple myeloma treatment, yet its clinical applications for other diseases such as solid cancers are limited due to low aqueous solubility and poor biostability. Ternary polypeptide nanoparticles (tPNPs) are drug carriers that we previ- ously reported to overcome these pharmaceutical limitations by entrapping CFZ in the core of the nanopar- ticles and protecting the drugs from degradation in biological media. However, preclinical studies revealed that tPNPs would require further improvement in particle stability to suppress initial burst drug release and thus achieve prolonged inhibition of proteasome activity with CFZ …


Nudcl2 Is Required For Cytokinesis By Stabilizing Rcc2 With Hsp90 At The Midbody, Xiaoyang Xu, Yuliang Huang, Feng Yang, Xiaoxia Sun, Rijin Lin, Jiaxing Feng, Mingyang Yang, Jiaqi Shao, Xiaoqi Liu, Tianhua Zhou, Shanshan Xie, Yuehong Yang Jan 2024

Nudcl2 Is Required For Cytokinesis By Stabilizing Rcc2 With Hsp90 At The Midbody, Xiaoyang Xu, Yuliang Huang, Feng Yang, Xiaoxia Sun, Rijin Lin, Jiaxing Feng, Mingyang Yang, Jiaqi Shao, Xiaoqi Liu, Tianhua Zhou, Shanshan Xie, Yuehong Yang

Markey Cancer Center Faculty Publications

Cytokinesis is required for faithful division of cytoplasmic components and duplicated nuclei into two daughter cells. Midbody, a protein-dense organelle that forms at the intercellular bridge, is indispensable for success- ful cytokinesis. However, the regulatory mechanism of cytokinesis at the midbody still remains elusive. Here, we unveil a critical role for NudC-like protein 2 (NudCL2), a co-chaperone of heat shock protein 90 (Hsp90), in cytokinesis regulation by stabilizing regulator of chromosome condensation 2 (RCC2) at the midbody in mam- malian cells. NudCL2 localizes at the midbody, and its downregulation results in cytokinesis failure, multinu- cleation, and midbody disorganization. Using iTRAQ-based …


Use Of Artificial Intelligence In Drug Development, Louise C. Druedahl, Nicholson Price, Timo Minssen, Dipl Jur, Ameet Sarpatwari Jan 2024

Use Of Artificial Intelligence In Drug Development, Louise C. Druedahl, Nicholson Price, Timo Minssen, Dipl Jur, Ameet Sarpatwari

Articles

Considerable focus has been placed on the health care applications of artificial intelligence (AI). Already, machine learning, a subset of AI that involves “the use of data and algorithms to imitate the way that humans learn” has been used to predict diseases, while AI-powered smartphone apps have been developed to promote mental health and weight loss. Owing in part to such successes, the market for AI in health care has been forecasted to increase more than 1000% between 2022 and 2029, from $13.8 billion to $164.1 billion. One area of substantial promise is drug development, which is poised to benefit …


ปัจจัยที่สัมพันธ์กับการเกิดค่าไอเอ็นอาร์ที่สูงเกินเป้าหมายในผู้ป่วยที่ได้ยาวาร์ฟารินที่มีภาวะหัวใจล้มเหลวเฉียบพลัน, รติยา รุ่งเรือง Jan 2024

ปัจจัยที่สัมพันธ์กับการเกิดค่าไอเอ็นอาร์ที่สูงเกินเป้าหมายในผู้ป่วยที่ได้ยาวาร์ฟารินที่มีภาวะหัวใจล้มเหลวเฉียบพลัน, รติยา รุ่งเรือง

Chulalongkorn University Theses and Dissertations (Chula ETD)

การศึกษานี้มีวัตถุประสงค์เพื่อ (1) ศึกษาปัจจัยที่สัมพันธ์กับการเกิดค่าไอเอ็นอาร์ที่สูงเกินเป้าหมายในผู้ป่วยที่รักษาด้วยวาร์ฟารินและเกิดภาวะหัวใจล้มเหลวเฉียบพลัน และ (2) เปรียบเทียบการเปลี่ยนแปลงของค่าไอเอ็นอาร์ขณะเกิดภาวะหัวใจล้มเหลวเฉียบพลัน เมื่อแบ่งกลุ่มตามค่าการบีบตัวของหัวใจห้องล่างซ้าย วิธีการวิจัยเชิงวิเคราะห์แบบย้อนหลังจากเหตุไปหาผลในผู้ป่วยที่ได้รับยาวาร์ฟารินที่แผนกผู้ป่วยใน เข้ารับรักษาด้วยภาวะหัวใจล้มเหลวเฉียบพลัน ระหว่าง 1 มกราคม พ.ศ. 2558 ถึง 30 กันยายน พ.ศ. 2566 วิเคราะห์ปัจจัยที่มีความสัมพันธ์กับการเกิดค่าไอเอ็นอาร์มากกว่า 4 ด้วยสถิติการถดถอยโลจิสติคพหุคูณ ที่ระดับนัยสำคัญทางสถิติที่ p


Perspectives On Using Pharmacogenomics To Guide Tobacco Cessation: Survey Results From An American Indian Community, Daniela Mariana Wall Jan 2024

Perspectives On Using Pharmacogenomics To Guide Tobacco Cessation: Survey Results From An American Indian Community, Daniela Mariana Wall

Graduate Student Theses, Dissertations, & Professional Papers

Pharmacogenomics research has predominantly focused on populations of European ancestry, limiting the application for diverse populations such as American Indian and Alaska Native (AIAN) communities. Our community-centric study aims to understand perspectives of utilizing pharmacogenomics to guide tobacco cessation in an AIAN community using a survey with qualitative and quantitative components. We assessed participant (n=273) tobacco usage and cessation history, pharmacogenomics knowledge, and perceptions of utilizing pharmacogenomics in the context of tobacco cessation. We found that the majority of participants (92%) were aware of risks associated with tobacco usage and believe it to be a problem within their community (76%). …


Addressing Inappropriate Polypharmacy: Investigating Perceived Facilitators And Barriers To U.S. Pharmacists' Ability To Recommend Deprescribing, Susanne Steiner Jan 2024

Addressing Inappropriate Polypharmacy: Investigating Perceived Facilitators And Barriers To U.S. Pharmacists' Ability To Recommend Deprescribing, Susanne Steiner

Theses and Dissertations

While the concurrent use of multiple prescriptions (polypharmacy) is common for those with chronic conditions, professional ownership is lacking when it comes to tapering or discontinuing potentially inappropriate medications. Our growing elderly population is especially vulnerable to negative risks associated with polypharmacy. Pharmacists are highly educated and skilled healthcare professionals working as critical touchpoints with patients; yet they are not empowered to deprescribe potentially inappropriate medications directly. This qualitative research study examined the perceived barriers and facilitators pharmacists encounter when pursuing deprescribing recommendations and initiatives with prescribers, healthcare staff, patients, and caregivers. Findings from this study revealed three key implications …


Alopecia As An Early Clinical Marker For Azathioprine Induced Myelosuppression: A Case Report, Nilanjana Dutta , Final Year Mbbs, Dr. M Suresh Babu , Professor, Dr. Subramanian Ramaswamy , Professor, Dr. Mahabaleshwar Mamadapur , Assistant Professor Jan 2024

Alopecia As An Early Clinical Marker For Azathioprine Induced Myelosuppression: A Case Report, Nilanjana Dutta , Final Year Mbbs, Dr. M Suresh Babu , Professor, Dr. Subramanian Ramaswamy , Professor, Dr. Mahabaleshwar Mamadapur , Assistant Professor

Digital Journal of Clinical Medicine

Azathioprine is a pro-drug and is metabolized by the TPMT enzyme in the body. In South Asians, Azathioprine is known to cause alopecia and bone marrow suppression in patients with TPMT enzyme deficiency. In India, the prevalence of TPMT mutation varies from 1.2- 10%. A new mutation was detected in 2014, NUDT15 whose incidence varies from 8.5-16%. Patients with mutation in both TPMT and NUDT15 develop myelosuppression faster. In our case, alopecia manifested as the first clinical feature of Azathioprine myelosuppression. Physicians need to recognize early clinical clues (alopecia) to avoid the impending development of myelosuppression and to look for …


Drugging The Histone Acetyltransferase Ep300 Modulates Alternative Splicing At Schizophrenia Risk Genes, Shravani Malay Jan 2024

Drugging The Histone Acetyltransferase Ep300 Modulates Alternative Splicing At Schizophrenia Risk Genes, Shravani Malay

Theses and Dissertations

Purpose. We will evaluate the effects of drugging the epigenetic histone acetyltransferase (HAT) enzyme p300, encoded by the schizophrenia risk gene EP300, on genome-wide gene expression in neural cells. We hypothesize that drugging p300 will affect gene expression and alternative splicing of other schizophrenia risk genes. Our motivation is to identify potential new epigenetic treatment avenues for schizophrenia.

Methods. Prior to my joining the lab, an experiment was conducted using the novel p300 HAT inhibitor, A-485, to modulate genomic regulation in a neural cell line (SH-SY5Y). SH-SY5Y cells were exposed to 10μM of A-485 or vehicle (DMSO) for 24 …


Exploration Of Dopaminergic And Serotonergic Pathways Utilizing Pleiotropic Agents, Charles B. Jones Iii Jan 2024

Exploration Of Dopaminergic And Serotonergic Pathways Utilizing Pleiotropic Agents, Charles B. Jones Iii

Theses and Dissertations

2-(Benzoyl)piperidines (BPs) are at a crossroads of therapy and abuse. These compounds are a hybrid between the ADHD medication methylphenidate and abused stimulant cathinones. Here we use computational molecular modeling, synthesis, mutagenesis, and epifluorescence microscopy to further improve the understanding of and potential treatments for several neuropsychiatric disorders. Utilizing the BP scaffold and controlling chirality and aryl substitution, these agents were examined at DAT and SERT. From these investigations it has now been established that R isomer BPs are favored for DAT while S isomer BPs are favored for SERT. Aryl-substitution can greatly affect the selectivity of these agents with …


Aadej Comm 10 3 2024 Jan 2024

Aadej Comm 10 3 2024

AADEJ - The Communicator

The Communicator is the official journal of the American Association of Dental Editors and Journalists (AADEJ). It is published quarterly, distributed digitally via email to members, and posted on the Association's website, AADEJ.org. Each issue includes regular updates from the editorial team and AADEJ board, as well as feature articles on current issues in the field.


2,3,4 Trihydroxybenzoic Acid, A Plant Secondary Metabolite Inhibits Cancer Cell Growth, Mina Akter Jan 2024

2,3,4 Trihydroxybenzoic Acid, A Plant Secondary Metabolite Inhibits Cancer Cell Growth, Mina Akter

Electronic Theses and Dissertations

Nature offers many sources such as fruits, beverage crops, vegetables, herbs, spices, tea, dark chocolate, and wine, that are rich in hydroxybenzoic acids (HBAs). They are a prominent phenolic acids with excellent biochemical and antioxidant properties. Due to the vast dietary health benefits of HBAs such as anti-inflammatory, anti-allergenic, immunoregulatory, antimicrobial, antithrombotic, antidiabetic, anticancer properties and cardioprotective capabilities, they are attracting the attention of physicians and researchers alike to understand their mechanisms of action. It is anticipated that the understanding of the role of HBAs for their greater use in diet/supplements is beneficial to reverse common illnesses such as inflammation, …